![Janet Hammond](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Janet Hammond
Corporate Officer/Principal chez
ATEA PHARMACEUTICALS, INC.
Fortune : 600 026 $ au 31/07/2026
Profil
Janet Hammond is currently Director at Enterprise Therapeutics Ltd. since 2024, Chief Development Officer at Atea Pharmaceuticals, Inc. since 2020, and Vice President-Translational Medicine at Roche Ltd. since 2011.
Former positions include Group Director-Virology Clinical Research at Bristol Myers Squibb Co., Chief Medical Officer, SVP & Head-Medical Affairs at Bausch Health Americas, Inc., SVP & Head-China Infectious Disease at F.
Hoffmann-La Roche Ltd. from 2011 to 2016, Chief Medical Officer, SVP & Head-Medical Affairs at Valeant Pharmaceutical, VP, Head-General Medicine & Infectious Disease at AbbVie, Inc. from 2016 to 2020, Head-Clinical Discovery at GSK Plc, and Senior Clinical Research Physician at Glaxo Wellcome, Inc. Education includes a doctorate from the University of Cape Town and graduate studies at Johns Hopkins Bloomberg School of Public Health.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 24/04/2026 | 127 665 ( 0,16 % ) | 600 026 $ | 31/07/2026 |
Postes actifs de Janet Hammond
| Sociétés | Poste | Début |
|---|---|---|
| ATEA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/08/2020 |
Roche Ltd.
 Roche Ltd. Financial ConglomeratesFinance Provides investment services | Corporate Officer/Principal | 29/03/2011 |
Enterprise Therapeutics Ltd.
 Enterprise Therapeutics Ltd. BiotechnologyHealth Technology Develops novel therapies to patients suffering with respiratory diseases | Directeur/Membre du Conseil | 01/05/2024 |
Anciens postes connus de Janet Hammond
| Sociétés | Poste | Fin |
|---|---|---|
| ABBVIE INC. | Corporate Officer/Principal | 01/08/2020 |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/11/2016 |
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals | Directeur Technique/Scientifique/R&D | 12/09/2011 |
Valeant Pharmaceutical | Directeur Technique/Scientifique/R&D | - |
| BRISTOL-MYERS SQUIBB COMPANY | Directeur Technique/Scientifique/R&D | - |
Formation de Janet Hammond
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
81
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals | Health Technology |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Atea Pharmaceuticals, Inc.
 Atea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes antiviral therapeutics | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Cape Town
 University of Cape Town Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Ltd.
Roche Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
Glaxo Wellcome, Inc.
 Glaxo Wellcome, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical preparations | Health Technology |
Johns Hopkins Bloomberg School of Public Health
 Johns Hopkins Bloomberg School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enterprise Therapeutics Ltd.
Enterprise Therapeutics Ltd. BiotechnologyHealth Technology Develops novel therapies to patients suffering with respiratory diseases | Health Technology |
Valeant Pharmaceutical |
